News tagged with pfizer
Clinical study of epilepsy drug may have been purely promotional
Yale School of Medicine researchers have found that a clinical trial of the epilepsy drug gabapentin may have been a "seeding trial" used by a pharmaceutical company to promote the drug and increase prescriptions, according ...
Medications
Jun 27, 2011 |
5 / 5 (3) |
0
|
Study reveals how the world's first drug for amyloid disease works
Scientists from The Scripps Research Institute and Pfizer Inc. have published a new study showing how a new drug called tafamidis (Vyndaqel) works. Tafamidis, approved for use in Europe and currently under ...
Medical research
May 29, 2012 |
5 / 5 (3) |
0
|
FDA clears Pfizer drug for advanced kidney cancer
(AP) -- The Food and Drug Administration has approved a new Pfizer drug for patients with advanced kidney cancer that has spread to other parts of the body despite treatment with at least one previous drug.
Medications
Jan 27, 2012 |
5 / 5 (2) |
0
Bristol-Pfizer anticlot drug gets key EU approval
European regulators have approved a crucial new anticlotting drug, Eliquis, for preventing strokes and dangerous clots in the circulatory system.
Medications
Nov 20, 2012 |
5 / 5 (2) |
0
Canada, Uganda test drug to treat brain disease
Canada is funding testing in Uganda of a popular off-patent antidepressant drug to fight a fungal brain disease that claims more than half a million lives in sub-Saharan Africa every year.
Medications
May 01, 2013 |
5 / 5 (2) |
0
Soviet-era pill from Bulgaria helps smokers quit
(AP) -- A pill developed in Bulgaria during the Soviet era shows promise for helping millions of smokers cheaply and safely kick the habit, the first big study of it shows.
Health
Sep 28, 2011 |
4.5 / 5 (2) |
0
Pfizer maneuvers to protect Lipitor from generics
(AP) -- Lipitor is so valuable that its maker, Pfizer Inc., is practically paying people to keep taking the blockbuster cholesterol medicine after generic competition hits the U.S. market this week.
Medications
Nov 29, 2011 |
3.5 / 5 (2) |
0
EMPHASIS HF: Study shows epleronone to reduce atrial fibrillation
The aldosterone antagonist eplerenone (Inspra, Pfizer) significantly reduced the development of new onset atrial fibrillation and flutter (AFF) in patients with class 2 heart failure, concludes a sub-analysis of the EMPHASIS-HF ...
Cardiology
May 22, 2011 |
5 / 5 (1) |
0
Antibody-guided drug works against acute lymphoblastic leukemia
An antibody packaged with a potent chemotherapy drug to selectively destroy acute lymphoblastic leukemia (ALL) cells eradicated or greatly reduced the disease for 61 percent of 46 patients in a phase II study. It will be ...
Cancer
May 23, 2011 |
5 / 5 (1) |
0
|
US approves India's Ranbaxy to make generic Lipitor
Indian pharmaceutical giant Ranbaxy won US regulatory approval to make the first generic version of cholesterol lowering drug Lipitor, a Pfizer product whose patent expired Wednesday.
Medications
Dec 01, 2011 |
5 / 5 (1) |
0
Smoking is an independent risk factor for psoriasis
(HealthDay) -- Smoking is an independent risk factor for psoriasis, with particularly strong associations for heavy smokers and those who have smoked for many years, according to research published in the ...
Inflammatory disorders
Mar 07, 2012 |
5 / 5 (1) |
1
Gene-based test identifies poor-prognosis colon cancers
(HealthDay) -- A sensitive and specific gene-based classifier can be used to identify BRAF mutant colon cancer tumors and a subpopulation of BRAF wild-type tumors with poor prognosis, according to a study pu ...
Cancer
Mar 09, 2012 |
5 / 5 (1) |
0
Alzheimer's drug sharply criticized by medical experts
Watching Alzheimer's disease steal away the memory, talents and very selves of its victims is hard enough for the people who love them. But a new pill formulated by a respected pharmaceutical company and approved by the Food ...
Alzheimer's disease & dementia
Mar 23, 2012 |
5 / 5 (1) |
0
Anti-clot drug recommended for new approval in EU
(AP)—Advisers to European Union regulators have recommended approval of a new anti-clotting drug for use by adults with a common irregular heart rhythm that boosts risk of strokes or blood clots, drugmakers Bristol-Myers ...
Medications
Sep 21, 2012 |
5 / 5 (1) |
0
MicroRNA-218 targets medulloblastoma, most aggressive childhood brain cancer
Between the blueprint of the genome and the products of its expression lie microRNAs, which can boost or lower the rate at which genes become stuff. In fact, many cancers use microRNA to magnify the expression of faulty genes ...
Cancer
Dec 13, 2012 |
5 / 5 (1) |
0
|
Pfizer
Pfizer Incorporated (NYSE: PFE) is a pharmaceutical company, ranking number one in sales in the world. The company is based in New York City, with its research headquarters in Groton, Connecticut. It produces Lipitor (atorvastatin, used to lower blood cholesterol); the neuropathic pain/fibromyalgia drug Lyrica (pregabalin); the oral antifungal medication Diflucan (fluconazole), antibiotic Zithromax (azithromycin), Viagra (sildenafil citrate), and the anti inflammatory Celebrex (celecoxib) (also known as Celebra in some countries outside USA and Canada, mainly in South America).
Pfizer's shares were made a component of the Dow Jones Industrial Average on April 8, 2004.
On January 26, 2009, Pfizer agreed to buy pharmaceutical giant Wyeth for US$68 billion, a deal financed with cash, shares and loans.
For more information about Pfizer, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
